A proprietary filtered-music listening protocol used as a possible supportive intervention—with careful pacing, monitoring and transparent evidence boundaries.
What Is the Safe and Sound Protocol?
The Safe and Sound Protocol, or SSP, is a proprietary listening intervention developed by Unyte. It uses acoustically modified music delivered through headphones and is marketed as a way to influence auditory processing and autonomic regulation.
The developer describes a core program containing five hours of music, usually delivered in shorter sessions according to the individual’s tolerance. Additional listening programs are also available. The exact product, version and pacing should be stated rather than referring generally to “sound therapy.”
At THE BALANCE, SSP may be considered only as a supportive component of a broader treatment plan. It is not a stand-alone treatment for a diagnosis and is not required for recovery.
A Proprietary Protocol
SSP is a commercial, branded intervention rather than an open clinical technique. Delivery depends on licensed access, provider training and the manufacturer’s platform or audio materials.
Informed consent should make this clear. Clients should know who developed the protocol, what evidence comes from the manufacturer or affiliated researchers, what costs or licenses apply, and how listening data are handled.
A proprietary name does not establish effectiveness. The intervention should be judged by relevant independent evidence, client response and integration with established care.
How the Listening Program Is Delivered
Listening typically takes place through headphones in a quiet environment, with session length and frequency adapted by the provider. Some clients listen while resting; others may use gentle grounding or simple activity.
The provider checks the client’s state before, during and after listening. Volume, device fit, music selection, session duration and environmental demands can affect tolerance. Longer sessions are not automatically better.
If symptoms increase, the response may be to shorten, pause or stop rather than interpret activation as necessary progress.
SSP Is Not Music Therapy or Sound Healing
SSP uses music but is not the same as Music Therapy. Music therapy is delivered by a qualified music therapist through an active therapeutic relationship and may involve improvisation, songwriting, listening and reflection.
SSP is also different from Sound Healing, which is generally offered as a complementary sensory or relaxation practice using tones, bowls or ambient sound.
Nor is SSP neurofeedback, biofeedback or direct vagus-nerve stimulation. It does not measure physiology in real time and does not electrically stimulate a nerve.
The Relationship With Polyvagal Theory
SSP was developed within the framework of Polyvagal Theory, which proposes that the autonomic nervous system supports different defensive and social-engagement states and assigns particular roles to vagal pathways and auditory processing.
Polyvagal language can help some clients describe activation, shutdown and connection. However, central anatomical and evolutionary claims of the theory remain actively debated. In 2026, an international group of experts published a detailed critique, and proponents published responses defending the theory.
The uncertainty should be represented on this page and on the separate Polyvagal Theory page. A useful metaphor does not prove every proposed mechanism.
What SSP Is Proposed to Support
Providers may use SSP with goals related to auditory sensitivity, stress regulation, social engagement, attention, anxiety or trauma-related symptoms. Much of the published work has involved children or neurodevelopmental and sensory populations.
These proposed applications should not be converted into claims that SSP treats a condition. A client’s diagnosis, age, symptom pattern and treatment needs require independent assessment.
Where THE BALANCE considers SSP for an adult mental-health or addiction client, the team should state the specific target and why the protocol is being considered rather than relying on a broad nervous-system explanation.
Evidence and Current Limitations
Research on sound-based interventions, including filtered-music and related protocols, reports preliminary positive findings for some outcomes. Reviews also identify substantial heterogeneity, small samples, limited controls and a need for stronger randomised trials.
Evidence for listening or music interventions generally cannot be assumed to validate SSP specifically. Studies of Polyvagal Theory do not automatically demonstrate that the commercial protocol works.
THE BALANCE should describe the evidence as emerging and uncertain, use measurable goals, and avoid presenting SSP as equivalent to established psychotherapy, medication or medical treatment.
Auditory and Sensory Screening
Headphone listening and acoustically modified music may be uncomfortable for people with hearing loss, tinnitus, hyperacusis, migraine, vestibular symptoms, sensory sensitivity or certain neurological conditions. Equipment fit and volume require attention.
An audiological or medical opinion may be appropriate where hearing or neurological symptoms are significant. SSP should not be used to diagnose auditory-processing disorder.
A client who dislikes headphones or filtered sound should not be pressured to continue. Preference and tolerability are legitimate clinical information.
Trauma, Dissociation and Emotional Response
Music and immersive listening can evoke memories, grief, agitation, numbness or dissociation. For some trauma survivors, reduced environmental awareness through headphones may feel unsafe.
Trauma-informed delivery may include shorter sessions, eyes open, a visible exit, external grounding, lower volume and active choice about when to stop. The provider should remain available rather than leaving the client unsupported with an audio program.
Distress is not proof that the protocol is accessing or releasing trauma. Significant worsening requires clinical review.
Possible Adverse Experiences
Reported experiences in practice include fatigue, headache, irritability, emotional lability, sleep changes, sensory discomfort, anxiety or increased activation. The frequency and causality of adverse effects are not well established because systematic monitoring is limited.
Providers should record adverse responses and distinguish temporary discomfort from clinically significant deterioration. A standard instruction to reduce session length may not be sufficient when new psychiatric, neurological or auditory symptoms appear.
The client should know how to contact the treatment team and when listening should stop.
SSP and Mental Health Treatment
SSP may be considered as an adjunct for a narrow goal, but it does not replace psychotherapy, psychiatric assessment or medication. Depression, anxiety, PTSD, OCD, psychosis, bipolar disorder and other conditions require condition-specific formulation.
If a client improves while receiving several treatments, the contribution of SSP may remain uncertain. The team should avoid attributing all change to the listening protocol.
When the protocol increases arousal or distracts from more important work, it should be modified or discontinued.
SSP in Addiction Recovery
Addiction recovery can involve stress, sleep disturbance, cue reactivity and difficulty tolerating internal states. SSP may be proposed as a supportive regulation exercise, but there is insufficient evidence to present it as an addiction treatment.
It does not manage withdrawal, craving, overdose risk or relapse and does not replace medication, addiction counselling, environmental change or continuing care.
The protocol should not be scheduled during medically unstable withdrawal or used to explain physical symptoms that need assessment.
Provider Training and Clinical Responsibility
SSP delivery requires provider access and training specified by the developer. Completion of product training does not by itself qualify someone to assess complex psychiatric, neurological, trauma or addiction presentations.
The named provider should have an appropriate clinical or therapeutic scope, access to supervision and a clear escalation pathway. Responsibility for the overall treatment remains with the relevant clinical lead.
Marketing should distinguish “SSP provider” status from regulated professional credentials.
Data, Devices and Privacy
The intervention may involve a digital platform, account data and manufacturer-controlled software. Clients should know what personal data are collected, where they are stored, who can access them and whether listening activity is logged.
Headphones and playback devices should meet hygiene and safety requirements. Personal devices may create additional privacy risks.
For executives, public figures and HNW or UHNW clients, data minimisation and access control are important, but they do not justify omitting clinically necessary records.
Assessment Before SSP
Assessment considers the client’s goals, hearing, tinnitus, migraines, sensory profile, trauma, dissociation, sleep, neurological history, psychiatric stability, medication, substance use and previous response to music or headphones.
The team should identify a measurable target, expected duration, alternatives and stopping criteria. Informed consent should explain the proprietary nature of the protocol, the relationship to Polyvagal Theory and the limits of current evidence.
Acute psychosis, mania, severe dissociation, intoxication, withdrawal or immediate safety concerns require another priority.
SSP Within the THE BALANCE Model
At THE BALANCE, SSP may be considered through Assessment and Treatment Planning as one optional neurobiological technique. It should be coordinated with psychiatry, psychotherapy, addiction care and trauma-informed treatment.
Within fully private residential treatment, listening can be paced around one client and monitored before and after the session. This creates flexibility but does not strengthen the evidence base.
The protocol should have a limited, explicit role. It is not a defining feature of THE BALANCE’s one-client model and should be stopped when the burden or uncertainty outweighs benefit.
How Progress and Discontinuation Are Evaluated
Progress may be assessed through the specific target selected before treatment, such as tolerance of sound, sleep, anxiety, participation or recovery after stress. General claims of feeling “regulated” should be translated into observable function where possible.
Improvement should be considered alongside other treatment changes and natural variation. Listening completion is not an outcome by itself.
The protocol can be shortened, paused or discontinued. The client should not be told that stopping means they are resistant or insufficiently committed to recovery.
Questions to Ask Before Starting SSP
Clients and advisers should ask which SSP program will be used, how many listening minutes are proposed, who monitors sessions, what training and clinical qualifications the provider holds, and what evidence supports the specific target.
They should also ask about headphones, volume, data storage, adverse-response procedures and whether the client can stop without pressure. The provider should explain the disputed status of Polyvagal Theory and distinguish manufacturer claims from independent research.
A credible plan includes measurable outcomes and stopping criteria. Completion of all listening hours should never be treated as more important than the client’s safety or the effectiveness of established care.
